Company

WAI BIO

WAI BIO develops AI software to identify potential breast implant complications from ultrasound images.

About

WAI BIO's platform analyzes ultrasound images for possible issues following breast augmentation and reconstruction. Founded in 2023 by Kim Jae-hong, the company is based in Seoul, South Korea. It received seed funding from Korea Tech Incubator for Startup in August 2024.

1Funding rounds

1Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in